Pratesi G, Pezzoni G, Giardini R, Doci R, Valente M, Parmiani G
Tumori. 1986 Aug 31;72(4):351-6. doi: 10.1177/030089168607200403.
Specimens from human colorectal tumors and from non-small-cell lung tumors obtained at surgery were subcutaneously implanted as xenografts in athymic Swiss mice of both sexes to investigate to what extent the properties of the original tumors were maintained. A successful take was obtained in 5 of 9 colorectal tumor and 6 of 11 non-small-cell lung tumor xenografts. Moreover, 44% and 45% of the respective tumors could be established as tumor lines. Neither metastases nor local tumor invasion was observed in tumor-bearing mice. Seven of 9 serially transplantable tumors had a short latency period (14-30.5 days) when first xenografted. No significant changes in tumor histopathology were noted after growth into nude mice. Tumor take was partially related to clinical stage and prognosis of patients. In fact, 8 of 12 specimens from N0 patients failed to grow, whereas 7 of 8 tumors from patients with nodal invasion and/or metastasis grew in nude mice. Moreover, for the group of patients whose tumor was "take - ", the one-year survival was 85%, compared to 40% for the "take + " group (p less than 0.05).
取自人类结肠直肠癌和非小细胞肺癌的手术标本被皮下植入到雌雄皆有的无胸腺瑞士小鼠体内作为异种移植,以研究原始肿瘤的特性在多大程度上得以保留。9个结肠直肠癌异种移植中有5个成功植入,11个非小细胞肺癌异种移植中有6个成功植入。此外,各自肿瘤的44%和45%能够建立成肿瘤系。在荷瘤小鼠中未观察到转移或局部肿瘤侵袭。9个可连续传代移植的肿瘤中有7个在首次异种移植时潜伏期较短(14 - 30.5天)。在裸鼠中生长后,肿瘤组织病理学未发现显著变化。肿瘤植入部分与患者的临床分期和预后相关。事实上,12个来自N0期患者的标本中有8个未能生长,而8个来自有淋巴结侵犯和/或转移患者的肿瘤中有7个在裸鼠中生长。此外,对于肿瘤“未植入”组的患者,一年生存率为85%,而“植入”组为40%(p小于0.05)。